SHREE GANESH REMEDIES
Back to Cashflow Statement
|
SHREE GANESH REMEDIES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-6.08 Cr | ₹7.28 Cr | ₹1.20 Cr | ₹-5.47 Cr |
What is the latest Net Cash Inflow / Outflow ratio of SHREE GANESH REMEDIES ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹-6.08 Cr |
| Mar2024 | ₹7.28 Cr |
| Mar2020 | ₹1.20 Cr |
| Mar2019 | ₹-5.47 Cr |
How is Net Cash Inflow / Outflow of SHREE GANESH REMEDIES Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹-6.08 Cr | Negative | |
| Mar2024 | ₹7.28 Cr | 505.66 | |
| Mar2020 | ₹1.20 Cr | Positive | |
| Mar2019 | ₹-5.47 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹622.9 Cr | 2.4% | -1.4% | -36.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹397,018.0 Cr | -2.3% | -8.5% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,454.0 Cr | 5.3% | -3.4% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,702.0 Cr | 3.7% | -4.9% | 26% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,830.0 Cr | 1.2% | -4.2% | 5.3% | Stock Analytics | |
| CIPLA | ₹99,325.0 Cr | 2.4% | -7.2% | -18.1% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | 2.4% |
-1.4% |
-36.1% |
| SENSEX | 5.8% |
-1.7% |
1.2% |
You may also like the below Video Courses